ARCHIVES

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

This article is from The Cancer Letter archive.

Vol. 33 No. 15 | April 20, 2007

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

March 21, 1997

Breast Cancer Overview Correlates Incidence Increase With Other Factors

July 29, 1988

Cancer Letter Founder Receives ACCC Award, Stresses Importance Of Bypass Budget

March 20, 1992

FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response

June 17, 1988

Federal AIDS Funds Tp $2 Bil.; Term Proposed For NIH Director

October 19, 1990

NCI Cooperative Group Clinical Trials Listed

April 24, 2009